Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.
about
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscleMolecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapiesLong pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesisAttenuation of corneal neovascularization by topical low-molecular-weight heparin-taurocholate 7 without bleeding complicationHeparin oligosaccharides as potential therapeutic agents in senile dementiaCell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein.Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A.Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats.Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.Cross-talk between endothelial and tumor cells via basic fibroblast growth factor and vascular endothelial growth factor signaling promotes lung cancer growth and angiogenesis.Angiogenesis: is it the key to controlling the healing process?Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis.HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsFibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptidePolyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.A review of the current research on the role of bFGF and VEGF in angiogenesis.Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphateInteraction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Designing Biopolymer Microthreads for Tissue Engineering and Regenerative Medicine.Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells.Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention.Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation.Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling.Fibroblast growth factor 2-induced angiogenesis in zebrafish: the zebrafish yolk membrane (ZFYM) angiogenesis assay.Bioactive polysaccharides from natural resources including Chinese medicinal herbs on tissue repair.Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise.VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle.RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats.Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide.FGFR1 mediates recombinant thrombomodulin domain-induced angiogenesis.Fibroblast growth factor 2 involved in the pathogenesis of synovial chondromatosis of temporomandibular joint.
P2860
Q24311344-61C4C3E1-D479-4E90-8930-6BD619A94C69Q28079232-2E79BCCD-C038-420A-88B2-EF1645442413Q28118263-DAF9388B-2505-46CA-86D9-561557DD45BBQ28829757-A8356856-D080-4694-BD35-A921FFB7B883Q33965772-F3B166ED-2563-4DEE-8453-E891F8303D08Q34048021-6E5B1E75-6B74-41B0-A035-9F07130FC6F0Q34087175-CF06B17C-10C9-4578-892E-95E78ECAE686Q34123753-AD297257-7348-4B4D-A5FA-883C3AD99DBDQ34147551-B70FBB39-8175-4851-B3E2-6FD17871AC25Q34189632-5F20B55F-0DE7-4F7C-8049-F89B1E09CA52Q35042233-2743A81E-504F-44AC-9505-5F3DDC4BBC59Q35215338-E191F790-B864-4D6C-885E-8CAFB450420FQ35855109-D19DDBD3-F46E-4934-8173-F7CCD8431F83Q36221840-11298477-69CA-4F9B-AC66-77D54430FA65Q36489766-CEC054D0-21ED-4BEB-BD3F-A449CA296000Q36526260-6450B521-80EC-41A6-B043-5C5B6328DD91Q37294970-98C6C23B-16AD-4130-8EB5-939CCC3DD47FQ37323266-7581FF0C-5851-4987-9441-E5D93478A172Q37676825-D4AEC8DC-03A5-48C4-BADF-F10F7F80AE83Q37997765-C963F98E-F60A-496D-9743-F2E2C0769AA3Q38309783-1740421E-690C-4014-902D-D4F459EF9777Q38328525-48661EEB-1DEB-4E0A-A361-7972586E2E18Q38418286-2810076E-8116-43E0-8F6F-4D921DDB2427Q38819917-649FA3D7-7DB8-4E42-9128-EF223A55442AQ38974266-60565EFF-3A15-4DB1-885F-806FD7720CD8Q39304663-E8333DD4-4F79-416C-8DD9-1FECA5FD6D9CQ39634552-042E0F57-5071-4AB7-9503-3A138313C546Q40486878-B3467CBC-25D3-498E-862A-32FA0936F027Q41041796-717FF671-6D1B-4632-AAFA-6B38EB2E7FFBQ41045856-35A80A7D-564B-4571-94E6-9FA9A13881C3Q42498167-B991674A-5CCF-4390-844C-D880FEC5CF71Q46461130-FD49E013-DCE5-4CAD-A1AF-F1034D97F49BQ49362954-C56F6BFE-BBFA-42B9-BBAE-D6EE8AAD1947Q50905577-73E752EC-111B-40D2-8052-C8761D7016D1Q51119496-1612AB31-CA54-4E4C-B86C-974BF5E5FE3EQ52183204-6F60CA6C-D7A7-40C7-BAF9-7FC76B50EA5EQ53292200-87A8ABC0-2626-4CEE-A632-2FBCBA7A99B1Q54310188-75F7CCCC-73D5-497D-91FC-D71A5A9051F8Q54392341-63375BD4-2515-4121-BD59-B1E39C1E8650
P2860
Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Interaction of angiogenic basi ...... cations in neovascularization.
@en
type
label
Interaction of angiogenic basi ...... cations in neovascularization.
@en
prefLabel
Interaction of angiogenic basi ...... cations in neovascularization.
@en
P356
P1476
Interaction of angiogenic basi ...... ications in neovascularization
@en
P2093
P2888
P356
10.1007/BF02644769
P577
1996-01-01T00:00:00Z
P6179
1003382429